1. Market Research
  2. > Advanced IT Market Trends
Asia Pacific Artificial Intelligence in Healthcare Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Component, Application, End User

Asia Pacific Artificial Intelligence in Healthcare Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Component, Application, End User

  • March 2021
  • 201 pages
  • ID: 6064909
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The Asia Pacific artificial intelligence (AI) in healthcare market is expected to reach US$ 17,797.42 million in 2027 from US$ 622.92 million in 2019. The market is estimated to grow with a CAGR of 50.8% from 2020 to 2027.

The growth of this market is attributed to the key driving factors such as the increasing public-private investments in the integration of AI in healthcare and the burgeoning partnerships among market players. However, the market is expected to experience slow growth during the forecast period owing to the lack of expertise in artificial intelligence and non-uniform regulatory guidelines for medical software.

Artificial Intelligence is among the most important technological developments in the healthcare sector; numerous startups are developing AI-driven imaging and diagnostic solutions that are accountable for the market’s growth.China-based AI healthcare start-ups have benefited from the government’s AI-focused development strategy, inspiring investment and private-public partnerships.

Shanghai-based medical AI startup, Synyi raised US$ 36.3 million (RMB 250M) in Series C funding by Chinese tech giant Tencent in July 2019. Synyi started with Natural Language Processing (NLP) abilities in the Chinese language and focused on hospitals’ demand for scientific research data, joining AI & HIT to create their primary smart analytics platform. Moreover, 12 Sigma Technologies, a Chinese company that provides medical data analysis software, makes medical diagnoses by employing deep learning. The company raised US$ 29 million in funding and is supported by SB China Venture Capital. iCarbonX uses advanced data and AI to cure disease with received funding of more than US$ 200 million from several investment firms, such as Tencent and China Bridge Capital.

Moreover, Tricog, an Indian healthcare analytics startup, used artificial intelligence and machine learning algorithm for wellness, screening, and diagnosis of acute and chronic heart diseases. The firm raised US$10.5 million in a Series B round of funding. The investment comes in from Aflac Ventures, LLC, Japan; UTEC - The University of Tokyo Edge Capital, Japan; and TeamFund, USA and Dream Incubator. Similarly, in July 2018, Kleiner Perkins and GV funded US$ 21 million in Viz.ai-an AI in a healthcare start-up. Further, HealthPlix Technologies Pvt. Ltd. raised US$ 3 million in a Series A funding round headed by Kalaari Capital and IDG Ventures India in July 2018. Besides, companies are progressively associating with AI startups as incumbents look to startups to help them compete with newer entrants entering the space. Microsoft partners with KenSci, for the development of artificial intelligence and a machine learning-powered risk prediction platform. Moreover, in February 2019, KenSci secured around US$ 22 million in series B financing directed by Polaris Partners, Ignition Partners, Osage University Partners, Mindset Ventures, and new strategic investor UL Ventures. Similarly, NVIDIA collaborates with Paige.AI, which uses AI for cancer pathology. Therefore, the increasing public-private investments in artificial intelligence in the healthcare sector are anticipated to positively influence market growth during the forecast period.

The COVID-19 has spread to more than 170 countries, including China prompting the WHO to declare the disease as a global pandemic.In China, in February 2020, Baidu, in association with Oregon State University and the University of Rochester, published its Linearfold prediction algorithm to study protein folding.

The algorithm is much quicker than conventional algorithms in forecasting the structure of a virus’s secondary ribonucleic acid (RNA) and provides scientists with additional information on how viruses spread. Linearfold would have calculated the forecast of the secondary structure of the RNA sequence of COVID-19 27 seconds instead of 55 minutes.

In Japan, in May 2020, FUJIFILM Corporation commenced a research study to develop AI-based technology to help in the diagnosis and treatment assessment of patients with COVID-19-induced pneumonia. The company embarks on a collaborative research study with regional medical universities managing COVID-19 patients, beginning with the Kanagawa Cardiovascular and Respiratory Center.

Improvements in AI employment such as natural language processing, data analytics, speech recognition, deep learning, machine learning, chatbots, and facial recognition have been used for investigation, contact tracing, and vaccine development.AI aided the restriction of the COVID-19 pandemic and supported controlling its worst consequences.

Hence, such outbreaks continue the need for new technologically advanced products nationwide, thereby positively impacting the market growth.

Based on component, the Asia Pacific artificial intelligence (AI) in healthcare market is segmented into software solution, hardware, and services. The software solution segment held the largest market share in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on application, the Asia Pacific artificial intelligence (AI) in healthcare market is segmented into robot assisted surgery, virtual assistants, administrative workflow assistants, connected machines, diagnosis, clinical trials, fraud detection, cybersecurity, dosage error reduction, and others. The clinical trials segment held the largest market share in 2019, whereas the robot assisted surgery segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on end user, the Asia Pacific artificial intelligence (AI) in healthcare market is segmented into hospitals & healthcare providers, patients, pharma & biotech companies, healthcare payers, and others. The hospitals & healthcare providers segment held the largest market share in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the Asia Pacific artificial intelligence (AI) in healthcare market are The University of Tokyo Edge Capital (UTEC), Global AI Talent (2019), among others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Artificial Intelligence in Healthcare Market by Offering, Technology, Application, End User and Geography - Global Forecast to 2027

  • $ 4950
  • October 2021
  • 253 pages

The artificial intelligence in healthcare market is projected to grow from USD 6.9 billion in 2021 to USD 67.4 billion by 2027; it is expected to grow at a CAGR of 46.2%from 2021 to 2027. Many companies ...

  • World
  • United States
  • Healthcare
  • Artificial Intelligence
  • Industry analysis
  • Health Provider Density
  • Medical Technology Density

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on